Functional imaging of interleukin 1 beta expression in inflammatory process using bioluminescence imaging in transgenic mice

BMC Immunology

Volumn 9, Issue , 2008, Pages

  Li, Limei ^a,b,d   Fei, Zhaoliang ^b   Ren, Jianke ^a,b   Sun, Ruilin ^a,b   Liu, Zhihui ^a   Sheng, Zhejin ^c   Wang, Long ^b   Sun, Xia ^b   Yu, Jun ^e   Wang, Zhugang ^b   Fei, Jian ^b,c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b Shanghai Research Center for Model Organisms   (China)

^c TONGJI UNIVERSITY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e Shanghai Genomics Inc   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; FIREFLY LUCIFERASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; OXAZOLONE; ZYMOSAN; PHOTOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; GENE INDUCTION; IMAGING SYSTEM; IN VIVO STUDY; INFLAMMATORY DISEASE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SKIN ALLERGY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; GENE EXPRESSION; GENETICS; IMMUNOLOGY; RHEUMATIC FEVER; TRANSACTIVATION;

ANIMALS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; LUCIFERASES, FIREFLY; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RHEUMATIC FEVER; SEPSIS; TRANS-ACTIVATION (GENETICS); ZYMOSAN;

EID: 51349160026     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-9-49     Document Type: Article

References (33)

1. Dinarello CA Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist Int Rev Immunol 1998, 16(5-6):457-499. 10.3109/ 08830189809043005 9646173
2. Dinarello CA Biologic basis for interleukin-1 in disease Blood 1996, 87(6):2095-2147. 8630372
3. Sasaki H Sato T Yamauchi N Okamoto T Kobayashi D Iyama S Kato J Matsunaga T Takimoto R Takayama T Kogawa K Watanabe N Niitsu Y Induction of heat shock protein 47 synthesis by TGF-beta and IL-1 beta via enhancement of the heat shock element binding activity of heat shock transcription factor 1 J Immunol 2002, 168(10):5178-5183. 11994473
4. Shahbakhti H Watson RE Azurdia RM Ferreira CZ Garmyn M Rhodes LE Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo Photochem Photobiol 2004, 80(2):231-235. 10.1562/2004-01-27-RA-066.1 15362934
5. Keystone EC Jaglal S Shore A Interleukin 1 and interleukin 2 generation by peripheral blood cells from patients with ankylosing spondylitis J Rheumatol 1986, 13(5):944-947. 3493347
6. Lanzrein AS Johnston CM Perry VH Jobst KA King EM Smith AD Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: Interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin Alzheimer Dis Assoc Disord 1998, 12(3):215-227. 10.1097/00002093-199809000-00016 9772027
7. Cannon JG Friedberg JS Gelfand JA Tompkins RG Burke JF Dinarello CA Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans Crit Care Med 1992, 20(10):1414-1419. 10.1097/00003246-199210000-00009 1395662
8. Casey LC Balk RA Bone RC Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 1993, 119(8):771-778. 8379598
9. Fisher CJ Jr. Slotman GJ Opal SM Pribble JP Bone RC Emmanuel G Ng D Bloedow DC Catalano MA Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial Crit Care Med 1994, 22(1):12-21. 10.1097/00003246-199401000-00267 8124953
10. Fisher CJ Jr. Dhainaut JF Opal SM Pribble JP Balk RA Slotman GJ Iberti TJ Rackow EC Shapiro MJ Greenman RL et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group Jama 1994, 271(23):1836-1843. 10.1001/jama.271.23.1836 8196140
11. Antin JH Weinstein HJ Guinan EC McCarthy P Bierer BE Gilliland DG Parsons SK Ballen KK Rimm IJ Falzarano G et al. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease Blood 1994, 84(4):1342-1348. 8049450
12. Cogswell JP Godlevski MM Wisely GB Clay WC Leesnitzer LM Ways JP Gray JG NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site J Immunol 1994, 153(2):712-723. 8021507
13. Sadikot RT Jansen ED Blackwell TR Zoia O Yull F Christman JW Blackwell TS High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice Am J Respir Crit Care Med 2001, 164(5):873-878. 11549548
14. Contag PR Olomu IN Stevenson DK Contag CH Bioluminescent indicators in living mammals Nat Med 1998, 4(2):245-247. 10.1038/nm0298-245 9461201
15. Carlsen H Moskaug JO Fromm SH Blomhoff R In vivo imaging of NF-kappa B activity J Immunol 2002, 168(3):1441-1446. 11801687
16. Jeon YJ Han SH Lee YW Lee M Yang KH Kim HM Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation Immunopharmacology 2000, 48(2):173-183. 10.1016/S0162-3109(00)00199-5 10936515
17. Tsao PW Suzuki T Totsuka R Murata T Takagi T Ohmachi Y Fujimura H Takata I The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis Clin Immunol Immunopathol 1997, 83(2):173-178. 10.1006/clin.1997.4333 9143378
18. Zhang Y Xu J Zhong N [Proinflammatory cytokine stimulated NF-kappa B activation and the effect of dexamethasone in the human airway epithelial cells] Zhonghua Jie He He Hu Xi Za Zhi 2000, 23(5):296-299. 11778222
19. Greten FR Arkan MC Bollrath J Hsu LC Goode J Miething C Goktuna SI Neuenhahn M Fierer J Paxian S Van Rooijen N Xu Y O'Cain T Jaffee BB Busch DH Duyster J Schmid RM Eckmann L Karin M NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta Cell 2007, 130(5):918-931. 10.1016/ j.cell.2007.07.009 17803913
20. Deinzer R Granrath N Stuhl H Twork L Idel H Waschul B Herforth A Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model Brain Behav Immun 2004, 18(5):458-467. 10.1016/ j.bbi.2003.11.008 15265539
21. Kumkumian GK Lafyatis R Remmers EF Case JP Kim SJ Wilder RL Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription J Immunol 1989, 143(3):833-837. 2545778
22. Eastgate JA Symons JA Wood NC Grinlinton FM di Giovine FS Duff GW Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis Lancet 1988, 2(8613):706-709. 10.1016/ S0140-6736(88)90185-7 2901567
23. Tamura T Matsubara M Hasegawa K Ohmori K Karasawa A Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity Clin Exp Allergy 2005, 35(1):97-103. 10.1111/ j.1365-2222.2005.02147.x 15649273
24. Olmos A Giner RM Recio MC Rios JL Cerda-Nicolas JM Manez S Effects of plant alkylphenols on cytokine production, tyrosine nitration and inflammatory damage in the efferent phase of contact hypersensitivity Br J Pharmacol 2007. 17660848
25. Auron PE Webb AC Interleukin-1: A gene expression system regulated at multiple levels Eur Cytokine Netw 1994, 5(6):573-592. 7727690
26. Shirakawa F Saito K Bonagura CA Galson DL Fenton MJ Webb AC Auron PE The human prointerleukin 1 beta gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction Mol Cell Biol 1993, 13(3):1332-1344. 359442 8441379
27. Buras JA Monks BG Fenton MJ The NF-beta A-binding element, not an overlapping NF-IL-6-binding element, is required for maximal IL-1 beta gene expression J Immunol 1994, 152(9):4444-4454. 8157962
28. Buras JA Reenstra WR Fenton MJ NF beta A, a factor required for maximal interleukin-1 beta gene expression is identical to the ets family member PU.1. Evidence for structural alteration following LPS activation Mol Immunol 1995, 32(8):541-554. 10.1016/0161-5890(95)00018-A 7609733
29. Kominato Y Galson D Waterman WR Webb AC Auron PE Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1 Mol Cell Biol 1995, 15(1):58-68. 231908 7799967
30. Galson DL Hensold JO Bishop TR Schalling M D'Andrea AD Jones C Auron PE Housman DE Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis Mol Cell Biol 1993, 13(5):2929-2941. 359686 8474451
31. Guglielmi L Le Bert M Truffinet V Cogne M Denizot Y Insulators to improve expression of a 3(')IgH LCR-driven reporter gene in transgenic mouse models Biochem Biophys Res Commun 2003, 307(3):466-471. 10.1016/ S0006-291X(03)01185-9 12893244
32. Zhang N Weber A Li B Lyons R Contag PR Purchio AF West DB An inducible nitric oxide synthase-luciferase reporter system for in vivo testing of anti-inflammatory compounds in transgenic mice J Immunol 2003, 170(12):6307-6319. 12794164
33. Zhang N Fang Z Contag PR Purchio AF West DB Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse Blood 2004, 103(2):617-626. 10.1182/ blood-2003-06-1820 14512298